Segmental neurofibromatosis in association with a large congenital nevus and malignant melanoma

Dermatology Online Journal

Volumn 12, Issue 7, 2006, Pages

  Doherty, Sean D ^a   George, Saira ^a   Prieto, Victor G ^b   Gershenwald, Jeffrey E ^c   Duvic, Madeleine ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BIOPSY TECHNIQUE; CASE REPORT; CLINICAL FEATURE; CONGENITAL NEVUS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MELANOMA; NEUROFIBROMATOSIS; SKIN EXAMINATION; MIDDLE AGED; NEVUS; PATHOLOGY; SKIN TUMOR;

HUMANS; MALE; MELANOMA; MIDDLE AGED; NEUROFIBROMATOSES; NEVUS; SKIN NEOPLASMS;

EID: 33845598936     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tinschert S, Naumann I, Stegmann E, et al. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet. 2000; 8: 455-9.
2. Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatosis. Neurology. 2001; 56(11): 1433-43.
3. Huson SM, Ruggieri M. The neurofibromatoses. In Harper J, Oranje JM, Prose N, eds. Pediatric Dermatology. Malden, MA: Blackwell Science; 2000, 1204-1224.
4. McCarron KF, Goldblum JR. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor. Mod Pathol. 1998; 11: 612-7.
5. Kluwe L, Friedrich RE, Mautner VF. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet. 1999; 113: 65-9.
6. Riccardi VM. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press; 1992.
7. Woodruff JM. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet. 1999; 89: 23-30.
8. Happle R. Large plexiform neurofibromas may be explained as a type 2 segmental manifestation of neurofibromatosis 1. Am J Med Genet. 2001; 98: 363-364.
9. Suzuki H, Takahashi K, Yasumoto K, Shibahara S. Activation of the tyrosinase gene promoter by neurofibromin. Biochem Biophys Res Commun. 1994; 205(3): 1984-91.
10. Suzuki H, Kazuhiro T, Yasumoto K, et al. Role of neurofibromin in modulation of expression of the tyrosinase-related protein 2 gene. J Biochem (Tokyo). 1998; 124(5): 992-8.
11. Castilla EE, da Graca Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I. Incidence rates and relativefrequencies. Br J Dermatol. 1981; 104: 307-15.
12. Brasfield RD, Das Gupta TK. Von Recklinghausen's disease: a clinicopathological study. Ann Surg. 1972; 175: 86-104.
13. Crowe FW, Schull WJ, Neel JV. A clinical, pathological and genetic study of multiple neurofibromatosis. Springfield, IL: Charles C Thomas Publishers, 1956.
14. Rubenstein AE, Seitz SC, Wallace S, et al. Increased risk of congenital premalignant melanocytic nevi in neurofibromatosis. Neurology. 1985; 35 (Suppl 1): 194.
15. Xu GF, O'Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990; 62(3): 599-608.
16. Bollag G, McCormick F. Ras Regulation. NF is enough of GAP. Nature. 1992; 356 (6371): 663-4.
17. Carr J, Mackie RM. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol. 1994; 131(1): 72-7.
18. Andersen LB, Fountain JW, Gutmann DH, et al. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet. 1993; 3: 118-21.
19. Johnson MR, Look AT, DeClue JE, et al. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. Proc Natl Acad Sci U S A. 1993; 90: 5539-43.
20. Gutzmer R, Herbst RA, Mommert S, et al. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet. 2000; 107: 357-61.
21. Zoller ME, Rembeck B, Oden A, et al. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997; 79: 2125-31.
22. Duve S, Rakoski J. Cutaneous melanoma in a patient with neurofibromatosis: a case report and review of the literature. Br J Dermatol. 1994; 131: 290-4.
23. Hendrickson MR, Ross JC. Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature. Am J Surg Pathol. 1981; 5(2): 109-35.
24. Jerdan MS, Cohen BA, Smith RR, Hood AF. Neuroectodermal neoplasms arising in congenital nevi. Am J Dermatopathol 1985; 7 Suppl: 41-48.
25. Yohay K. Neurofibromatosis types 1 and 2. Neurologist. 2006 Mar;12(2):86-93.
26. Fernandez MT, Puig L, Capella G, et al. Von Recklinghausen neurofibromatosis with carcinoid tumor and submucous leiomyomas of the duodenum. Neurofibromatosis. 1989;1:294-8.
27. Guillot B, Dalac S, Delaunay M, et al. Melanoma Res. 2004 Apr;14(2):159-63.
28. Lorentzen M, Pers M, Bretteville-Jensen G. The incidence of malignant transformation in giant pigmented nevi. Scand J Plast Reconstr Surg. 1977; 11(2): 163-7.
29. Rhodes AR, Wood WC, Sober AJ, Mihm MC Jr. Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg. 1981; 67: 782-790.